Synergistic TME Reprogramming via a Chemo-Free Triplet Strategy (Radiotherapy, Anlotinib, and Sintilimab) Salvages Rapidly Recurrent Dedifferentiated Chordoma (ESMO-IO 2026) - Oct 25, 2026 - Abstract #403P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Chordoma • Oncology
|
|
Hong-cheng Yang; Hai-Jing Yang; Hui yu Wu; Kunpeng Wu; Lei Chen; Hui Lin
|